BOSENTAN ARROW 125 mg, film-coated tablet scored 56 tablets
Active ingredients: Bosentan, Bosentan hydrate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet scored56 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- BOSENTAN ARROW 125 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 56 comprimé(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Sept 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67407786CIP73007320CIP133400930073209Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BOSENTANcomprimé | 125 mg · un comprimé | FT |
| BOSENTAN MONOHYDRATÉcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.